Geode Capital Management
MEDS

Geode Capital Management’s DataMeds AI, Inc. Common Stock MEDS Stock Holding History

Geode Capital Management’s Portfolio MEDS Stock Details MEDS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$68.5K Buy
14,215
+4,467
+46% +$61.3K ﹤0.01% 4235
2025
Q4 		$195K Buy
9,748
+4,364
+81% +$128K ﹤0.01% 3914
2025
Q3 		$239K Buy
+5,384
New +$284K ﹤0.01% 3864

Other funds holding MEDS

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
AA
ACT Advisors Asheville, North Carolina $301M AUM 23.36% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
VFIC
Valley Forge Investment Consultants Audubon, Pennsylvania $334M AUM 17.84% 1-Year Est. Return

Geode Capital Management's MEDS Position: Q1 2026 in Review

Geode Capital Management increased its DataMeds AI, Inc. Common Stock (MEDS) stake by 46% in Q1 2026, buying an estimated $61.3K and bringing the position to 14,215 shares worth $68.5K. The position accounts for ﹤0.01% of the portfolio, ranked #4235.

Geode Capital Management first reported a position in MEDS in Q3 2025 and has held it in 3 quarters since. The position peaked at $239K in Q3 2025. 13 funds tracked by Wall St. Rank hold MEDS as of Q1 2026.

  • Geode Capital Management held 14,215 shares of DataMeds AI, Inc. Common Stock worth $68.5K as of Q1 2026.
  • Geode Capital Management bought 4,467 DataMeds AI, Inc. Common Stock shares in Q1 2026, an estimated $61.3K.
  • DataMeds AI, Inc. Common Stock made up ﹤0.01% of Geode Capital Management's portfolio in Q1 2026, its #4235 holding.
  • Geode Capital Management first reported a position in DataMeds AI, Inc. Common Stock in Q3 2025 and has held it in 3 quarters since.
  • Geode Capital Management's DataMeds AI, Inc. Common Stock position peaked at $239K in Q3 2025.
  • 13 funds tracked by Wall St. Rank held DataMeds AI, Inc. Common Stock as of Q1 2026.

Based on Geode Capital Management's 13F filing for Q1 2026, filed 15 May 2026.